Engineered Lipid Nanoparticles Improve mRNA Vaccine Efficacy and Reduce Side Effects

Researchers have developed engineered lipid nanoparticles that reprogram immune metabolism to enhance mRNA vaccine performance while minimizing common side effects. This innovation addresses the well-documented issues of soreness and malaise associated with current vaccine formulations. The breakthrough represents a significant step forward in medical technology, potentially making vaccination safer and more effective for the general population.